PPARγ delivered by Ch-GNPs onto titanium surfaces inhibits implant-induced inflammation and induces bone mineralization of MC-3T3E1 osteoblast-like cells

Clin Oral Implants Res. 2013 Oct;24(10):1101-9. doi: 10.1111/j.1600-0501.2012.02517.x. Epub 2012 Jun 19.

Abstract

Objectives: To deliver the efficacy and safety of Ch-GNPs (Chitosan gold nanoparticles) conjugated anti-inflammatory molecules peroxisome proliferator activated receptor gamma (PPARγ) on implant surface titanium (Ti) to reduce implant-induced inflammation.

Materials and methods: The Ch-GNPs were conjugated with the PPARγ cDNA through a coacervation process. Conjugation was cast over Ti surfaces by dipping, and cells were seeded on different sizes (6 × 6 × 0.1 cm and 1 × 1 × 0.1 cm; n = 3) of Ti surfaces. The size of Ch-GNPs and surface characterization of Ti was performed using UV-vis spectroscopy, TEM (Transmission electron microscopy) and EDX (energy-dispersive X-ray). The DNA conjugation and transfection capacity of Ch-GNPs were simultaneously confirmed by agarose gel electrophoresis, β-galactosidase staining, and immunoblotting.

Results: The Ch-GNPs were well dispersed and spherical in shape, with average size around 10-20 nm. Ti surfaces coated with Ch-GNPs/LacZ, as transfection efficacy molecule, showed strong β-galactosidase staining in MC-3T3 E1 cells. Cells cultured on Ch-GNPs/PPARγ-coated Ti surfaces were able to inhibit implant-induced inflammation by simultaneously suppressing the expression of tumor necrosis factor- alpha (TNF-α), interleukin-1 beta (IL-1β), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-2 (MMP-2). The inhibition mechanism of Ch-GNPs/PPARγ was due to inhibition of both reactive oxygen species (ROS) and nitric oxide (NO) secretion (n = 3; P < 0.05). In addition, Ch-GNPs/PPARγ was able to increase expression of bone morphogenetic protein (BMP-7) and runt-related transcription factor-2 (RUNX-2). Furthermore, alkaline phosphatase activity (ALP) was also increased than that in control (n = 3; P < 0.01). Whereas, expression of receptor activator of NF-κB ligand (RANKL) was decreased.

Conclusions: The novel gene delivery materials, like Ch-GNPs, can carry the PPARγ cDNA into the required areas of the implant surfaces, thus aiding to inhibit inflammation and promote osteoblast function. Thus, the PPARγ on implant surfaces may promote its clinical application on peri-implantitis or periodontitis like diseases.

Keywords: PPARγ; bone mineralization; chitosan gold nanoparticles; gene delivery; inflammation; titanium implant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells / drug effects*
  • 3T3 Cells / metabolism
  • Alkaline Phosphatase / metabolism
  • Animals
  • Calcification, Physiologic / drug effects*
  • Chitosan / pharmacology*
  • Electrophoresis, Agar Gel
  • Gold / pharmacology*
  • Mice
  • Nanoparticles
  • Nitric Oxide / metabolism
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • PPAR gamma / pharmacology*
  • Peri-Implantitis / prevention & control*
  • Reactive Oxygen Species / metabolism
  • Spectrophotometry, Ultraviolet
  • Staining and Labeling
  • Surface Properties
  • Titanium / chemistry
  • Transfection

Substances

  • PPAR gamma
  • Reactive Oxygen Species
  • Nitric Oxide
  • Gold
  • Chitosan
  • Titanium
  • Alkaline Phosphatase